JP2020083892A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020083892A5 JP2020083892A5 JP2019212064A JP2019212064A JP2020083892A5 JP 2020083892 A5 JP2020083892 A5 JP 2020083892A5 JP 2019212064 A JP2019212064 A JP 2019212064A JP 2019212064 A JP2019212064 A JP 2019212064A JP 2020083892 A5 JP2020083892 A5 JP 2020083892A5
- Authority
- JP
- Japan
- Prior art keywords
- beraprost
- monohydrate
- solvent
- type
- following
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/199,471 | 2018-11-26 | ||
| US16/199,471 US10577341B1 (en) | 2018-11-26 | 2018-11-26 | Beraprost-314d monohydrate crystals and methods for preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020083892A JP2020083892A (ja) | 2020-06-04 |
| JP2020083892A5 true JP2020083892A5 (enExample) | 2021-03-25 |
| JP6894489B2 JP6894489B2 (ja) | 2021-06-30 |
Family
ID=68655416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019212064A Active JP6894489B2 (ja) | 2018-11-26 | 2019-11-25 | ベラプロスト−３１４ｄ・一水和物結晶及びその製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10577341B1 (enExample) |
| EP (1) | EP3656767A1 (enExample) |
| JP (1) | JP6894489B2 (enExample) |
| KR (1) | KR102317032B1 (enExample) |
| CN (1) | CN111217782A (enExample) |
| TW (1) | TWI724651B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11447440B2 (en) * | 2020-10-29 | 2022-09-20 | Chirogate International Inc. | Treprostinil monohydrate crystals and methods for preparation thereof |
| CN115611838A (zh) * | 2021-07-15 | 2023-01-17 | 四川国为制药有限公司 | 一种前列环素衍生物的晶型 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59134787A (ja) * | 1983-01-19 | 1984-08-02 | Toray Ind Inc | ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体の製造法 |
| JP4503942B2 (ja) * | 2003-06-11 | 2010-07-14 | 大正製薬株式会社 | 止痒剤 |
| KR101978530B1 (ko) * | 2011-06-16 | 2019-05-14 | 렁 바이오테크놀로지 피비씨 | 베라프로스트의 제조 방법 |
| AU2014235346A1 (en) * | 2013-03-15 | 2015-10-08 | Gemmus Pharma Inc. | Beraprost isomer as agent for the treatment of viral infection |
| CN103242274B (zh) * | 2013-05-22 | 2014-11-05 | 孙威 | 一种贝前列素钠化合物及其制备方法 |
| CA2949528A1 (en) * | 2014-05-20 | 2015-11-26 | Lung Biotechnology Pbc | Methods for producing beraprost and its derivatives |
| CA2995364C (en) * | 2015-08-12 | 2019-12-17 | United Therapeutics Corporation | Process for making beraprost |
| HU231080B1 (hu) * | 2016-04-05 | 2020-07-28 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Eljárás optikailag aktív Beraprost előállítására |
| KR101777632B1 (ko) * | 2016-04-11 | 2017-09-12 | 연성정밀화학(주) | 베라프로스트 나트륨 결정형 및 이의 제조방법 |
-
2018
- 2018-11-26 US US16/199,471 patent/US10577341B1/en active Active
-
2019
- 2019-11-25 JP JP2019212064A patent/JP6894489B2/ja active Active
- 2019-11-25 KR KR1020190152168A patent/KR102317032B1/ko active Active
- 2019-11-25 EP EP19211276.1A patent/EP3656767A1/en active Pending
- 2019-11-26 CN CN201911176459.6A patent/CN111217782A/zh active Pending
- 2019-11-26 TW TW108143007A patent/TWI724651B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110526914B (zh) | 一种alk抑制剂的多晶型物及其制备方法 | |
| JP4138886B2 (ja) | ２−アミノ−４−（４−フルオルベンジルアミノ）−１−エトキシカルボニル−アミノベンゼンの新規変態ならびにその製造法 | |
| TWI769272B (zh) | 奧美卡替莫卡必爾的合成 | |
| JP2022511800A5 (enExample) | ||
| JP2012500819A5 (enExample) | ||
| JP2007308494A (ja) | 結晶イマチニブ塩基及びその製造方法 | |
| JP2006137778A5 (enExample) | ||
| JP2005503386A5 (enExample) | ||
| CN1227233C (zh) | 纯晶形的5－氯－3－(4－甲磺酰基苯基)－6′－甲基－[2,3′]联吡啶及其合成方法 | |
| JP2022507251A5 (enExample) | ||
| JP2019505533A5 (enExample) | ||
| JP2020535168A5 (enExample) | ||
| JP7663642B2 (ja) | エラミプレチドの合成に有用な結晶性ジペプチド | |
| JP2019505532A5 (enExample) | ||
| JP2013505234A (ja) | ３−（４−アミノ−１−オキソ−１，３−ジヒドロ−イソインドール−２−イル）−ピペリジン−２，６−ジオンの固形体およびその製造方法 | |
| JP2024518429A5 (enExample) | ||
| JP2022505670A5 (enExample) | ||
| JP2018522945A5 (enExample) | ||
| JP2023530786A5 (enExample) | ||
| JP2022540678A5 (enExample) | ||
| AU2011284341A1 (en) | N-Methylformamide solvate of dasatinib | |
| WO2002096877A1 (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| AU2001292907A1 (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| WO2019196802A1 (zh) | 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用 | |
| JP2020535193A5 (enExample) |